List of Excipients in API loteprednol etabonate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing loteprednol etabonate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | BENZALKONIUM CHLORIDE | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | EDETATE DISODIUM | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | GLYCERIN | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | HYDROCHLORIC ACID | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | POVIDONE | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | SODIUM HYDROXIDE | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | TYLOXAPOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing loteprednol etabonate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Akorn | loteprednol etabonate | 17478-830 | BENZALKONIUM CHLORIDE |
| Akorn | loteprednol etabonate | 17478-830 | BORIC ACID |
| Akorn | loteprednol etabonate | 17478-830 | EDETATE DISODIUM |
| Akorn | loteprednol etabonate | 17478-830 | GLYCERIN |
| Akorn | loteprednol etabonate | 17478-830 | POLYCARBOPHIL |
| Akorn | loteprednol etabonate | 17478-830 | PROPYLENE GLYCOL |
| Akorn | loteprednol etabonate | 17478-830 | SODIUM CHLORIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for loteprednol etabonate
Excipient focus: BENZALKONIUM CHLORIDE
loteprednol etabonate drug variants containing BENZALKONIUM CHLORIDE
loteprednol etabonate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| Physicians Total Care Inc | loteprednol etabonate | 54868-4278 |
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
loteprednol etabonate drug variants containing BORIC ACID
loteprednol etabonate drug variants not containing BORIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
loteprednol etabonate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: EDETATE DISODIUM
loteprednol etabonate drug variants containing EDETATE DISODIUM
loteprednol etabonate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
loteprednol etabonate drug variants containing GLYCERIN
loteprednol etabonate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
loteprednol etabonate drug variants containing HYDROCHLORIC ACID
loteprednol etabonate drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
loteprednol etabonate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing HYPROMELLOSE
Excipient focus: MINERAL OIL
loteprednol etabonate drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing MINERAL OIL
Excipient focus: PETROLATUM
loteprednol etabonate drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing PETROLATUM
Excipient focus: POLOXAMER 407
loteprednol etabonate drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POLOXAMER 407
Excipient focus: POLYCARBOPHIL
loteprednol etabonate drug variants containing POLYCARBOPHIL
loteprednol etabonate drug variants not containing POLYCARBOPHIL
Excipient focus: POVIDONE
loteprednol etabonate drug variants containing POVIDONE
loteprednol etabonate drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
loteprednol etabonate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | loteprednol etabonate | 50383-265 |
| ARMAS PHARMACEUTICALS INC | loteprednol etabonate | 72485-653 |
| ARMAS PHARMACEUTICALS INC | loteprednol etabonate | 72485-665 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
loteprednol etabonate drug variants containing PROPYLENE GLYCOL
loteprednol etabonate drug variants not containing PROPYLENE GLYCOL
Excipient focus: SODIUM CHLORIDE
loteprednol etabonate drug variants containing SODIUM CHLORIDE
loteprednol etabonate drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
loteprednol etabonate drug variants containing SODIUM HYDROXIDE
loteprednol etabonate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
loteprednol etabonate drug variants containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate and tobramycin | 24208-358 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing SULFURIC ACID
Excipient focus: TRISODIUM CITRATE DIHYDRATE
loteprednol etabonate drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: TYLOXAPOL
loteprednol etabonate drug variants containing TYLOXAPOL
loteprednol etabonate drug variants not containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
loteprednol etabonate drug variants containing WATER
loteprednol etabonate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
